Header cover image

Indonesian (IDX) Pharma Industry Analysis

UpdatedApr 15, 2025
DataAggregated Company Financials
Companies9
  • 7D5.7%
  • 3M-1.0%
  • 1Y-19.4%
  • YTD-8.0%

The Pharma industry is up 1.7% in the last week, with Kalbe Farma up 9.3%. In the past year, the industry is down 22%. As for the next few years, earnings are expected to grow by 8.2% per annum.

Industry Valuation and Performance

Has the Indonesian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 15 Apr 2025Rp86.1tRp86.5tRp3.7t10.1x23.2x1x
Thu, 13 Mar 2025Rp76.6tRp70.6tRp3.1t12.1x24.3x1.1x
Sat, 08 Feb 2025Rp87.2tRp70.6tRp3.1t12.5x27.7x1.2x
Mon, 06 Jan 2025Rp90.7tRp70.6tRp3.1t12.7x28.8x1.3x
Wed, 04 Dec 2024Rp97.4tRp70.6tRp3.1t12.5x31x1.4x
Fri, 01 Nov 2024Rp106.2tRp69.1tRp3.3t12.4x32.4x1.5x
Sun, 29 Sep 2024Rp112.2tRp68.8tRp3.3t12.6x33.9x1.6x
Tue, 27 Aug 2024Rp108.4tRp68.9tRp3.4t12.8x31.6x1.6x
Thu, 25 Jul 2024Rp98.8tRp67.5tRp3.0t11.4x33.3x1.5x
Sat, 22 Jun 2024Rp97.0tRp67.4tRp3.1t15.4x31.4x1.4x
Mon, 20 May 2024Rp94.1tRp67.7tRp4.4t12.8x21.3x1.4x
Wed, 17 Apr 2024Rp92.9tRp66.6tRp4.4t14x21.2x1.4x
Fri, 15 Mar 2024Rp90.1tRp65.9tRp4.7t18.6x19x1.4x
Sun, 11 Feb 2024Rp93.7tRp65.9tRp4.7t17.2x19.8x1.4x
Tue, 09 Jan 2024Rp100.7tRp65.9tRp4.7t18.3x21.2x1.5x
Thu, 07 Dec 2023Rp104.3tRp66.0tRp4.8t20.7x21.9x1.6x
Sat, 04 Nov 2023Rp97.5tRp65.9tRp5.5t19.3x17.7x1.5x
Mon, 02 Oct 2023Rp106.2tRp65.6tRp5.4t22.2x19.7x1.6x
Wed, 30 Aug 2023Rp107.7tRp65.6tRp5.4t21.2x20x1.6x
Fri, 28 Jul 2023Rp112.7tRp64.2tRp5.3t21.3x21.2x1.8x
Sun, 25 Jun 2023Rp118.2tRp64.2tRp5.3t20.7x22.2x1.8x
Tue, 23 May 2023Rp123.4tRp64.2tRp5.3t21.2x23.2x1.9x
Thu, 20 Apr 2023Rp120.8tRp64.1tRp4.7t18.9x25.8x1.9x
Sat, 18 Mar 2023Rp124.2tRp65.0tRp4.6t20.3x26.9x1.9x
Mon, 13 Feb 2023Rp136.3tRp65.0tRp4.6t21x29.5x2.1x
Wed, 11 Jan 2023Rp122.5tRp65.0tRp4.6t21.8x26.5x1.9x
Fri, 09 Dec 2022Rp127.6tRp65.0tRp4.6t21.6x27.6x2x
Sun, 06 Nov 2022Rp120.7tRp64.8tRp4.6t15.8x26x1.9x
Tue, 04 Oct 2022Rp113.7tRp67.1tRp5.1t19.6x22.2x1.7x
Thu, 01 Sep 2022Rp109.3tRp67.0tRp5.1t17.6x21.6x1.6x
Sat, 30 Jul 2022Rp109.2tRp66.7tRp5.2t14.4x20.9x1.6x
Mon, 27 Jun 2022Rp111.3tRp66.7tRp5.2t14.4x21.3x1.7x
Wed, 25 May 2022Rp107.4tRp66.2tRp5.2t20.6x20.5x1.6x
Fri, 22 Apr 2022Rp108.1tRp64.6tRp5.3t23.6x20.3x1.7x
Price to Earnings Ratio

20.3x


Total Market Cap: Rp108.1tTotal Earnings: Rp5.3tTotal Revenue: Rp64.6tTotal Market Cap vs Earnings and Revenue0%0%0%
Indonesian Pharma Industry Price to Earnings3Y Average 24.5x202320242025
Current Industry PE
  • Investors are relatively neutral on the Indonesian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 24.5x.
  • The 3-year average PS ratio of 1.6x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 14% per year over the last three years.
  • Meanwhile revenues for these companies have grown 3.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Indonesian Healthcare industry?

ID Market-1.95%
Healthcare0.92%
Pharma5.72%
Pharma5.72%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
KLBF Kalbe FarmaRp1.20k13.3%
+Rp6.4t
-17.6%PE16.9x
TSPC Tempo Scan PacificRp2.44k6.6%
+Rp676.5b
27.1%PE7.6x
PYFA Pyridam FarmaRp180.0019.2%
+Rp325.9b
-81.1%PS1.1x
SOHO Soho Global HealthRp610.003.4%
+Rp253.8b
24.0%PE16.7x
KAEF Kimia FarmaRp418.009.4%
+Rp200.4b
-50.5%PS0.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MERK

Rp3,590.00

Merck

7D

11.8%

1Y

-10.5%

KAEF

Rp418.00

Kimia Farma

7D

9.4%

1Y

-50.5%

PEHA

Rp290.00

Phapros

7D

9.0%

1Y

-42.6%

PYFA

Rp180.00

Pyridam Farma

7D

19.2%

1Y

-81.1%

SOHO

Rp610.00

Soho Global Health

7D

3.4%

1Y

24.0%

KLBF

Rp1,195.00

Kalbe Farma

7D

13.3%

1Y

-17.6%

TSPC

Rp2,440.00

Tempo Scan Pacific

7D

6.6%

1Y

27.1%

DVLA

Rp1,490.00

Darya-Varia Laboratoria

7D

8.8%

1Y

0.3%